Medtronic (MDT) Revenue — Quarter Ended Jan 26, 2024
Revenue increased in the quarter, driven by higher sales compared to the prior period. Both sequential and year-over-year comparisons reflected positive growth.
Key takeaway
Quarter ended Jan 26, 2024 · FY2024 Q3
Revenue increased in the quarter, driven by higher sales compared to the prior period. Both sequential and year-over-year comparisons reflected positive growth.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$8.1B
Revenue reported for this quarter.
Quarter-over-quarter
+1.3%
Change from the immediately preceding quarter.
Year-over-year
+4.7%
Change from the comparable year-ago quarter.
Trailing four quarters
$32.3B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Apr 28, 2023 | $8.5B | +5.6% |
| Jul 28, 2023 | $7.7B | +4.5% |
| Oct 27, 2023 | $8B | +5.3% |
| Jan 26, 2024 | $8.1B | +4.7% |
Revenue performance
The reported revenue for the quarter was higher, indicating improved top-line performance.
Quarterly comparison
Revenue was above both the immediately preceding quarter and the same quarter one year earlier.
What to watch
Forward-looking statements in the filing highlight uncertainties from competition, regulatory changes, and supply chain risks.